4960 — Chemipro Kasei Kaisha Balance Sheet
0.000.00%
- ¥5bn
 - ¥8bn
 - ¥10bn
 
- 51
 - 60
 - 27
 - 42
 
Annual balance sheet for Chemipro Kasei Kaisha, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st  | 2022 March 31st  | 2023 March 31st  | 2024 March 31st  | 2025 March 31st  | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — | 
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho | 
| Standards: | JAS | JAS | JAS | JAS | JAS | 
| Status: | Final | Final | Final | Final | Final | 
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 2,137 | 1,911 | 957 | 1,883 | 2,149 | 
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2,465 | 2,433 | 2,731 | 2,735 | 2,355 | 
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 7,874 | 7,922 | 8,419 | 8,377 | 8,048 | 
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 5,404 | 5,196 | 5,021 | 4,933 | 4,709 | 
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 13,644 | 13,453 | 13,784 | 13,714 | 13,298 | 
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 5,970 | 6,374 | 6,454 | 6,198 | 6,007 | 
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 9,118 | 8,878 | 9,188 | 9,034 | 8,521 | 
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 4,525 | 4,575 | 4,596 | 4,680 | 4,777 | 
| Total Liabilities & Shareholders' Equity | 13,644 | 13,453 | 13,784 | 13,714 | 13,298 | 
| Total Common Shares Outstanding |